Phoenix and Raven Become First Canadian Telehealth Platforms to Offer Generic Semaglutide Direct to Patients

Eligible Canadians can now access Health Canada–approved generic semaglutide directly, by prescription, starting at $124.99 TORONTO — Today, Phoenix and Raven, leading Canadian digital health providers, announced the launch of generic semaglutide for direct-to-patient access in Canada, making them the first telehealth platform in the country to bring this medication to customers. Phoenix and Raven... The post Phoenix and Raven Become First Canadian Telehealth Platforms to Offer Generic Semaglutide Direct to Patients appeared first on Montreal Gazette .

Original source: Montreal Gazette